Dr. John W. Davis, MD

Dr. Davis practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Davis' NPI, 1740268978, was assigned on January 6, 2006. Dr. Davis graduated from UVA School of Medicine in 1994. Dr. Davis' Texas license number on file is L0785.

Dr. Davis' primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Davis' primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Davis is also affiliated with MountainView Hospital. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Davis practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Davis' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Davis is board certified in urology by the American Board of Urology. Dmand AI has Dr. Davis' licenses on file in 11 states: Texas, Florida, Georgia, Arizona, Louisiana, Tennessee, Washington, Alabama, Mississippi, Oklahoma and Virginia.

Dmand AI lists erectile dysfunction, prostate cancer, prostate surgery and urinary endoscopy among the conditions Dr. Davis treats.

CMS data shows 259 Medicare services from Dr. Davis across 7 procedure codes in 2024, for 191 Medicare patients. Medicare paid $82,398 for them.

CMS counts 191 Medicare patients who saw Dr. Davis in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Davis' median patient age at 70, with 3% women.

In 2024, Dr. Davis wrote 134 Medicare Part D claims for 63 patients. 92% of them were for generic drugs. CMS names the drug for 77 of them, across 3 drugs with 11 or more claims each, at $719 in total drug cost. In 2023, CMS named 64 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Davis for performance year 2024, reported as part of a group. Dr. Davis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Davis as offering telehealth. CMS counts 43 procedures of prostate resection by Dr. Davis, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 139 papers to Dr. Davis, published from 2004 to 2024. 2017 was the busiest year, with 10. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Prostate. Dr. Davis has published most often in J Urol. Dr. Davis' most frequent co-authors are Brian Francis Chapin, MD, Jeri Kim, MD and Curtis A. Pettaway, MD.

Dmand AI links Dr. Davis to 2 clinical trials. Conditions studied include Prostatic Neoplasms, Urinary Bladder Neoplasms and Prostatic Diseases. M.D. Anderson Cancer Center sponsors the most, 2.

CMS Open Payments shows 155 general payments to Dr. Davis from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Intuitive Surgical, Inc. paid the most, $43,889.

Dmand AI lists 1 award for Dr. Davis.

Dr. Davis graduated from UVA School of Medicine in 1994. Dr. Davis is a member of ACS.

Dr. Davis is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.